Literature DB >> 11525766

Prostaglandin E(2) increases surfactant secretion via the EP(1) receptor in rat alveolar type II cells.

M A Morsy1, Y Isohama, T Miyata.   

Abstract

Prostaglandin E(2), the predominant cyclooxygenase metabolite of arachidonic acid in alveolar type II cells, can stimulate pulmonary surfactant secretion. The actions of prostaglandin E(2) are mediated by four prostaglandin E (EP) receptor subtypes designated EP(1), EP(2), EP(3) and EP(4). These subtypes couple to different signal transduction pathways. However, it is not clear which of these subtypes is expressed on type II cells and mediates surfactant secretion. We found that the four subtypes of EP receptors are expressed on the primary cultured alveolar type II cells from adult rats. We also concluded that EP(1) receptor appears to mediate prostaglandin E(2)-induced surfactant secretion through Ca(2+) mobilization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525766     DOI: 10.1016/s0014-2999(01)01211-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Cholera toxin induces a shift from inactive to active cyclooxygenase 2 in alveolar macrophages activated by Mycobacterium bovis BCG.

Authors:  Mari Kogiso; Tsutomu Shinohara; C Kathleen Dorey; Yoshimi Shibata
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

2.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

3.  Yimu San improves obstetric ability of pregnant mice by increasing serum oxytocin levels and connexin 43 expression in uterine smooth muscle.

Authors:  Qi-Huan Wang; Shuang Zhang; Li-Meng Qin; Wen-Jun Zhang; Feng-Hua Liu; Jian-Qin Xu; Yun-Fei Ma; Ke-Dao Teng
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

4.  Persistent inactivation of macrophage cyclooxygenase-2 in mycobacterial pulmonary inflammation.

Authors:  Tsutomu Shinohara; Traci Pantuso; Shizuka Shinohara; Mari Kogiso; Quentin N Myrvik; Ruth Ann Henriksen; Yoshimi Shibata
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

5.  Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial.

Authors:  Margaret Harper; Elizabeth Thom; Mark A Klebanoff; John Thorp; Yoram Sorokin; Michael W Varner; Ronald J Wapner; Steve N Caritis; Jay D Iams; Marshall W Carpenter; Alan M Peaceman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan M Ramin; Garland D Anderson
Journal:  Obstet Gynecol       Date:  2010-02       Impact factor: 7.661

Review 6.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

7.  Gene expression profile of androgen modulated genes in the murine fetal developing lung.

Authors:  Eva Bresson; Tommy Seaborn; Mélissa Côté; Geneviève Cormier; Pierre R Provost; Bruno Piedboeuf; Yves Tremblay
Journal:  Reprod Biol Endocrinol       Date:  2010-01-08       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.